Back to BlackRock, Inc. BlackRock, Inc.

BBIOBBIO
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in BRIDGEBIO PHARMA INC

BlackRock, Inc. holds 10.3M shares of BBIO (BRIDGEBIO PHARMA INC), worth $766.2M as of 2026-Q2. The position was decreased (-27.6% shares). BBIO represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$766.2M

Current Shares

10.3M

Total Value Change

+$390M

Total Shares Change

-3.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
10.3M
-27.6%
$766.2M0.0%$74.48
0
2026-Q1
Decreased
14.2M
-2.4%
$1.1B0.0%$64.53
0
2025-Q4
Increased
14.5M
+1.0%
$1.1B0.0%$75.48
32
2025-Q3
Increased
14.4M
+1.1%
$748.5M0.0%$51.96
32
2025-Q2
Increased
14.3M
+6.8%
$615.7M0.0%$44.86
34
2025-Q1
Decreased
13.4M
-2.6%
$461.8M0.0%$35.11
0
2024-Q4
New
13.7M
-
$376.2M0.0%$27.32
43

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used